Merck and Moderna’s Intismeran Autogene Plus Keytruda Meets Phase 3 RFS and DMFS Endpoints in Resected Melanoma
FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma
FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand
Simplify Your ESO College Enrolment With Our New 3-Year Plan - ESO
ENZAMET: Enzalutamide Maintains Long-Term Survival Benefit in mHSPC
oncoHUB and OncoDaily Announce Strategic Partnership to Strengthen Ukrainian Oncology
Bridging the Care Gap: Expanding Humanitarian Access to CLL Treatment Across LMICs
Human Connection in Cancer Care with Dr. Aleksandra Filipovic - CancerWorld
The ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026, oorganized by the European Society for Medical Oncology (ESMO), will take place on 2–3 October 2026 in Singapore. […]
The ESMO Congress 2026 will take place from 23–27 October in Madrid, Spain, bringing together oncology professionals from around the world. This global event serves as a key platform for […]
The ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona is scheduled to take place in Barcelona, Spain, from November 11–12, 2026. This specialized educational program […]
The ESMO AI and Digital Oncology Congress 2026 will take place from November 16-18, 2026, in Berlin, Germany. This congress is designed as a central meeting point that facilitates the […]
The ESMO Asia Congress 2026 is the premier scientific platform in the Asia-Pacific region for oncology professionals, scheduled for December 4-6, 2026, in Singapore. Organized by the European Society for […]
The ESMO Immuno-Oncology Congress 2026 is a premier international event hosted by the European Society for Medical Oncology (ESMO), scheduled for December 14–16, 2026, as an onsite event in London, […]
The ESMO Congress 2027 will take place in Barcelona, Spain, from September 17–21, 2027. This event is recognized as a leading global oncology meeting that serves as a platform for […]
